Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives)

Cinnamomum verum
Evidence Level
Moderate
1 Clinical Trial
5 Documented Benefits
3/5 Evidence Score

Cinnamon FenuMat® is a PATENTED CINNAMON BARK EXTRACT formulated with FENUMAT® technology developed by Akay Bioactives — clinically substantiated for glucose management support. Distinguished by combination of cinnamon bioactives with FenuMat fenugreek galactomannan matrix for enhanced bioavailability. Used for: glucose management, metabolic health, insulin sensitivity adjunct.

Studied Dose Per Akay Cinnamon FenuMat product specification
Active Compound Cinnamon bark extract in FenuMat® matrix

Benefits

Glucose Management Support

Cinnamon FenuMat clinically substantiated for glucose management — modest improvements in fasting glucose, postprandial glucose, HbA1c.

FenuMat® Bioavailability Enhancement

Same FenuMat fenugreek matrix as other Akay products — enhances cinnamon bioactive delivery and absorption.

Insulin Sensitivity Adjunct

Combined cinnamon + fenugreek both modestly support insulin signaling.

Metabolic Health Markers

Effects extend beyond glucose to lipid profile and metabolic syndrome markers.

Coumarin Considerations Addressed

FenuMat technology may help address coumarin concerns of cassia cinnamon by extracting selectively.

Mechanism of action

1

Cinnamon Insulin Sensitization

Cinnamon compounds (methylhydroxychalcone polymer/MHCP) have insulin-mimetic activity in research.

2

Alpha-Glucosidase Inhibition

Modest alpha-glucosidase inhibition slows carbohydrate digestion.

3

Fenugreek Glucose Effects

Fenugreek's separate glucose effects (slowed gastric emptying, fiber effects) provide complementary mechanism.

4

FenuMat® Bioavailability

Fenugreek galactomannan matrix enhances bioactive delivery.

Clinical trials

1
Cinnamon FenuMat for Glucose Management — Akay Studies
PubMed

Akay Bioactives clinical evaluation of Cinnamon FenuMat for glucose applications.

Adults with glucose management concerns.

Glucose marker improvements.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
REDUCED COUMARIN concern vs unprocessed cassia cinnamon.
FENUGREEK ALLERGY consideration.
Allergic reactions to cinnamon or fenugreek possible.

Important Drug interactions

DIABETES MEDICATIONS — additive hypoglycemic effects from cinnamon + fenugreek; monitor; consult.
Anticoagulants — modest effects.
Antihypertensives — modest effects.
Pregnancy — fenugreek contraindicated in pregnancy; AVOID Cinnamon FenuMat in pregnancy.
Hepatically-metabolized medications — modest CYP interactions.
FENUGREEK ALLERGY consideration.

Frequently asked questions about Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives)

What is Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives)?

Cinnamon FenuMat® is a PATENTED CINNAMON BARK EXTRACT formulated with FENUMAT® technology developed by Akay Bioactives — clinically substantiated for glucose management support.

What does Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) do?

Cinnamon compounds (methylhydroxychalcone polymer/MHCP) have insulin-mimetic activity in research. In clinical research, Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) has been studied for glucose management support, fenumat® bioavailability enhancement, insulin sensitivity adjunct.

Who should take Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives)?

Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) may be most relevant for people interested in metabolic health. It has been clinically studied for glucose management support, fenumat® bioavailability enhancement, insulin sensitivity adjunct. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives)?

For cardiovascular or metabolic goals, Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) is typically taken with meals to support absorption and reduce GI sensitivity. Effects on biomarkers (cholesterol, blood pressure, blood sugar) build over 8-12+ weeks of consistent daily use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) worth taking?

Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives)?

The clinically studied dose for Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) is Per Akay Cinnamon FenuMat product specification. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) used for?

Cinnamon FenuMat® (Cinnamon Bark Extract — Akay Bioactives) is studied for glucose management support, fenumat® bioavailability enhancement, insulin sensitivity adjunct. Cinnamon FenuMat clinically substantiated for glucose management — modest improvements in fasting glucose, postprandial glucose, HbA1c.